Reltecimod TFA (AB-103 TFA) is a CD28 (T-lymphocyte receptor) mimetic that acts as a CD28 antagonist, inhibiting the stimulation of t-cells by a range of bacterial pathogens thereby attenuating acute inflammation for the treatment of necrotizing soft tissue infections (NSTI).
Molecular Weight:
1151.21
Purity:
99.24%
Formula:
C48H73F3N10O17S
Target:
Immunology/Inflammation related|||Antibacterial
T78107
* VAT and and shipping costs not included. Errors and price changes excepted
